Evoke Wealth’s Revance Therapeutics, Inc. RVNC Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q4 | – | Sell |
-300
| Closed | -$8K | – | 1187 |
|
|
2022
Q3 | $8K | Hold |
300
| – | – | ﹤0.01% | 808 |
|
|
2022
Q2 | $4K | Buy |
+300
| New | +$4K | ﹤0.01% | 959 |
|
|
2022
Q1 | – | Sell |
-115
| Closed | -$2K | – | 1269 |
|
|
2021
Q4 | $2K | Hold |
115
| – | – | ﹤0.01% | 1083 |
|
|
2021
Q3 | $3K | Hold |
115
| – | – | ﹤0.01% | 978 |
|
|
2021
Q2 | $3K | Hold |
115
| – | – | ﹤0.01% | 1014 |
|
|
2021
Q1 | $3K | Hold |
115
| – | – | ﹤0.01% | 983 |
|
|
2020
Q4 | $3K | Hold |
115
| – | – | ﹤0.01% | 851 |
|
|
2020
Q3 | $3K | Hold |
115
| – | – | ﹤0.01% | 808 |
|
|
2020
Q2 | $3K | Buy |
+115
| New | +$3K | ﹤0.01% | 828 |
|
|
2020
Q1 | – | Sell |
-426
| Closed | -$6.91K | – | 1377 |
|
|
2019
Q4 | $6.91K | Hold |
426
| – | – | ﹤0.01% | 843 |
|
|
2019
Q3 | $5.54K | Buy |
+426
| New | +$5.54K | ﹤0.01% | 975 |
|